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A cross-syndrome cohort comparison
of sleep disturbance in children with
Smith-Magenis syndrome, Angelman
syndrome, autism spectrum disorder
and tuberous sclerosis complex
J. Trickett1,2*, M. Heald2, C. Oliver2 and C. Richards2
Abstract
Background: Sleep disturbance is common in children with neurodevelopmental disorders, with high rates identified
in children with Smith-Magenis syndrome (SMS), Angelman syndrome (AS), autism spectrum disorder (ASD) and
tuberous sclerosis complex (TSC). Phenotypic sleep profiles for these groups may implicate different pathways to sleep
disturbance. At present, cross-group comparisons that might elucidate putative phenotypic sleep characteristics are
limited by measurement differences between studies. In this study, a standardised questionnaire was administered
across groups affording comparison of the prevalence and profile of sleep disturbance between groups and contrast
to chronologically age-matched typically developing (TD) peers.
Methods: The modified version of Simonds and Parraga’s sleep questionnaire, adapted for use in children
with intellectual disabilities, was employed to assess sleep disturbance profiles in children aged 2–15 years
with SMS (n = 26), AS (n = 70), ASD (n = 30), TSC (n = 20) and a TD contrast group (n = 47). Associations
between sleep disturbance and age, obesity, health conditions and overactivity/impulsivity were explored for
each neurodevelopmental disorder group.
Results: Children with SMS displayed severe night waking (81%) and early morning waking (73%). In contrast,
children with ASD experienced difficulties with sleep onset (30%) and sleep maintenance (43%). Fewer children with
ASD (43%) and AS (46%) experienced severe night waking compared to children with SMS (both p < .01). Higher
sleep-disordered breathing scores were identified for children with SMS (p < .001) and AS (p < .001) compared to
the TD group. Sleep disturbance in children with AS and TSC was associated with poorer health. Children experiencing
symptoms indicative of gastro-oesophageal reflux had significantly higher sleep-disordered breathing scores in the AS,
SMS and ASD groups (all p < .01). A number of associations between overactivity, impulsivity, gastro-oesophageal
reflux, age and sleep disturbance were found for certain groups.
(Continued on next page)
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Conclusions: These data reveal syndrome-specific profiles of sleep disturbance. The divergent associations between
sleep parameters and person characteristics, specifically symptoms of gastro-oesophageal reflux, overactivity and
impulsivity and age, implicate aetiology-specific mechanisms underpinning sleep disturbance. The differences in
prevalence, severity and mechanisms implicated in sleep disturbance between groups support a syndrome-sensitive
approach to assessment and treatment of sleep disturbance in children with neurodevelopmental disorders.
Keywords: Sleep disturbance, Cross-group comparison, Intellectual disability, Genetic syndromes, Angelman syndrome,
Smith-Magenis syndrome, Tuberous sclerosis complex, Autism spectrum disorder
Background
Sleep disturbance is common in children with neurodeve-
lopmental disorders [1] and associated with deleterious
outcomes for individuals and families, including elevated
levels of difficult behaviour and increased parental irrit-
ability and fatigue [2, 3]. A recent systematic review out-
lining the prevalence of sleep disturbance revealed that
children with Smith-Magenis syndrome (SMS) and Angel-
man syndrome (AS) evidenced the highest rates of sleep
disturbance (100 and 48–70% respectively) compared to
children with other rare genetic syndromes [1]. Similarly,
children with autism spectrum disorder (ASD) and tuber-
ous sclerosis complex (TSC) are reported to show strik-
ingly high rates of sleep disturbance (ASD 50–80% [4],
TSC 74% [5]). Despite these elevated prevalence rates,
there is limited research examining the profile of sleep
disturbance across these neurodevelopmental disorders,
specifically the relative contributions of settling problems,
night waking and early morning waking alongside para-
somnias, sleep anxiety and sleep-disordered breathing to
the presentation of sleep disturbance in each group. Thus,
there is a need to contrast profiles of sleep disturbance in
children with a range of neurodevelopmental disorders to
evaluate characteristics of sleep disturbance that are more
common in a phenotype but are shared by other pheno-
types [6]. The emergence of divergent profiles would sug-
gest that aetiology of neurodevelopmental disorder,
specifically the phenotypic characteristics of each neuro-
developmental disorder, is important in assessment and
intervention for sleep disturbances.
Within behavioural phenotype research, there is a de-
bate as to the most appropriate study design to assess the
partial specificity of behavioural characteristics [6], with
studies employing within and between syndrome designs,
and comparisons to mental or chronological age-matched
typically developing peers. The inclusion of a typically
developing contrast group may be particularly important
in sleep research as sleep is a universal state experienced
by mammals, entrained by the body’s circadian rhythm,
and hypothesised to consolidate learning, restore cells and
synaptic plasticity [7]. Sleep, therefore, is a necessary
health consideration for children regardless of disability.
To understand the degree of impairment in children with
neurodevelopmental disorders, it is necessary to consider
what is ‘typical’ in an aspect of health which has consider-
able interpersonal variability [8]. Importantly, sleep dis-
turbance in children with neurodevelopmental disorders
is hypothesised to be qualitatively commensurate to that
experienced by typically developing children, but more
pervasive and persistent [9].
The limited studies that have evaluated the profile of
sleep disturbance in SMS, AS, ASD and TSC compared
to TD children reveal some important syndrome-related
patterns. In SMS, shorter total sleep time, earlier bed-
times, earlier final morning wake times and an inverted
circadian rhythm have been identified in an actigraphy
study of eight children with SMS compared with age-
matched TD children [10]. A wide range of sleep distur-
bances were found in a questionnaire study including in-
dividuals with AS, namely overall shorter sleep duration
characterised by significantly longer sleep onset latency,
more frequent wakings with difficulty falling back to
sleep, significantly more frequent unusual movements
and jerking during sleep, sleep-disordered breathing and
more frequent daytime somnolence compared with age-
matched TD individuals [11]. In children with TSC,
shorter total sleep time, as assessed by polysomnography
and the modified Simonds and Parraga sleep question-
naire [12], is attributed to specific problems with settling
at sleep onset and night waking compared with TD chil-
dren [5, 13]. Sleep disturbance in children with ASD
may be differentiated from that of other neurodevelop-
mental disorder groups by greater bedtime resistance
and sleep anxiety compared to TD children, in addition
to higher scores on questionnaire measures of sleep-
disordered breathing, sleep onset delay, sleep duration
and night waking [14]. There has been substantial char-
acterisation of sleep disturbance in children with ASD,
but comparatively little evaluation of sleep parameters in
AS, SMS and TSC despite similar or higher prevalence
of sleep disturbance in these groups. Much of the
existing data are limited by small samples, lack of
validated questionnaires, omission of the study of para-
somnias and the lack of comparison with other neurode-
velopmental disorder groups. Thus, it is not possible to
draw comparisons between the groups to evaluate the
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potential for partial specificity as differing definitions of
sleep disturbance were used between studies. Therefore,
further research utilising a standardised measure of sleep
disturbance across these groups is warranted.
In addition to contrasting the profile of sleep disturb-
ance between neurodevelopmental groups, there is also
a need to elucidate associations between sleep parame-
ters and comorbid health and behaviour difficulties, in
addition to demographic variables such as age and verbal
ability. These contrasts will delineate whether patterns
of comorbidities with sleep disturbance are shared or di-
vergent across children with different neurodevelopmen-
tal disorders and may allude to syndrome-related
pathways to sleep disturbance.
A number of health conditions with heightened preva-
lence in children with neurodevelopmental disorders such
as epilepsy and gastro-oesophageal reflux have been asso-
ciated with sleep disturbance in typically developing and
clinical populations [15, 16]. Specifically, in AS, in which
seizures affect 80% of individuals [17], the presence of
multiple types of seizures and refractory epilepsy (77% of
individuals) have both been associated with parent-
reported sleep disturbance [18, 19]. However, two large-
scale studies [20, 21] have failed to replicate the
association between seizures and sleep quality in individ-
uals with AS perhaps due to methodological differences.
Seizures affect 70% of individuals with TSC [22]. Two
studies have reported a higher prevalence of night waking
in children with TSC who experienced seizures in the last
6 months or who had three or more nightly seizures [5,
13]. The contribution of anti-epilepsy drugs (AEDs) to
sleep quality requires consideration, as AEDs have been
found to both prolong total sleep time or induce daytime
sleepiness and disturb sleep quality or onset according to
self-report in adults with TSC [23]. Seizures also affect up
to 18% of children with SMS [24] and 30% of children
with ASD [25], with seizures associated with sleep disturb-
ance in children with ASD [26]. The putative associations
between sleep quality and epilepsy need elucidating
further to ensure that appropriate assessment protocols
and interventions to address any neurological aetiology of
sleep disturbance are developed.
In addition to epilepsy, children with SMS, AS, TSC
and ASD are also more likely to experience painful
health conditions than typically developing children.
These vary in aetiology between syndrome groups with
multi-organ tumours common in TSC, chronic otitis
media affecting children with SMS, scoliosis commonly
occurring in children with SMS and AS, and high
relative risk of gastrointestinal symptoms, asthma and
allergies in children with ASD [27–30]. The presence of
these health conditions is associated with sleep disturb-
ance. For example, obstructive sleep apnoea has been
associated with gastro-oesophageal reflux in children
without an intellectual disability [16]; similarly, children
with an intellectual disability who experience pain were
more likely to snore and have sleep-disordered breathing
problems [31]. In children with ASD, those with gastro-
intestinal problems and/or epilepsy were twice as likely
to have sleep problems [32]. Pain has also been associ-
ated with shorter sleep duration, more parasomnias and
sleep-disordered breathing in ASD [33]. Despite the high
prevalence of sleep disturbance and physical health con-
ditions, no studies have considered the putative associa-
tions between pain or gastro-oesophageal reflux and
sleep in children with AS, SMS and TSC.
Alongside painful health conditions, other adverse
health outcomes associated with poor sleep in the paediat-
ric population should also be evaluated in children with
neurodevelopmental disorders. Obesity is identified as an
independent risk factor for both snoring and obstructive
sleep apnoea in typically developing children [34]. Obesity
has been suggested as a risk factor for obstructive sleep
apnoea in children with SMS [35], and children with AS
may be at heightened risk of obesity due to purported im-
paired satiety and behaviours such as taking and storing
food [36]. Obesity may mediate the relationship between
obstructive sleep apnoea and daytime sleepiness, as de-
scribed in typically developing children [37], and requires
evaluation in these neurodevelopmental groups.
In summary, examining the putative associations
between sleep and painful health conditions, health
problems such as epilepsy and adverse health outcomes
such as obesity will provide clinicians with important
information about comorbidities between health and
sleep in children with neurodevelopmental disorders.
Describing these associations between neurode-
velopmental disorders will inform syndrome-sensitive
models of the development and maintenance of sleep
disturbance in these groups.
Finally, in contrast to physical health problems, there
are also demographic and behavioural characteristics pur-
ported to be associated with sleep disturbance. In the typ-
ically developing population and in children with
attention deficit and hyperactivity disorder (ADHD),
hyperactivity is associated with daytime sleepiness [38,
39], and in turn, hyperactivity and daytime sleepiness are
associated with sleep-disordered breathing [34, 40]. How-
ever, the relationship between ADHD characteristics, day-
time sleepiness and sleep-disordered breathing has not
been evaluated in children with neurodevelopmental dis-
orders, despite a clinical imperative associating ADHD
characteristics and parent stress in these groups [41].
A greater proportion of younger children experience
sleep problems than primary school-aged children in the
typically developing population [42, 43]. A meta-analysis
of sleep quality in children with intellectual disabilities
demonstrated that age was not significantly related to
Trickett et al. Journal of Neurodevelopmental Disorders  (2018) 10:9 Page 3 of 14
impaired sleep quality; however, as these data are cross-
sectional, they should be interpreted with caution [44].
The persistence of sleep problems across the develop-
mental trajectory of AS is unclear, as some cross-
sectional and longitudinal studies in small samples have
shown a reduction in the prevalence of sleep problems
after the age of 6 [45, 46]. However, other studies using
age as a correlate or comparing between arbitrary age
groups have suggested that sleep difficulties persist with
age [11, 21]. Increasing age is associated with more dis-
turbed sleep in SMS [47], whilst for children with ASD,
a shortened sleep duration is observed from the age of
30 months relative to typically developing peers [48].
The relationship between age and sleep quality has not
been examined in children with TSC. These findings
suggest that the relationship between age and sleep qual-
ity in children with specific syndromes needs to be ex-
amined further. Poorer receptive and expressive
language skills have been associated with poorer sleep
quality [49]. The relationship between children’s verbal
ability and sleep quality, particularly concerning chil-
dren’s ability to make their needs known during the
night, is an area that requires further research.
In summary, there is a need to describe the prevalence
and profile of sleep disturbance across neurodevelop-
mental disorders in order to evaluate the evidence for
partial specificity of sleep disturbance profiles related to
phenotypic characteristics. Additionally, there is a need
to evaluate the putative associations between sleep dis-
turbance and children’s health, overactivity and impul-
sivity, age and ability in each group to determine the
likelihood of syndrome-specific pathways to sleep dis-
turbance. The use of a typically developing contrast
group will enable the comparative severity of sleep dis-
turbance in each neurodevelopmental group to be quan-
tified relative to age-expected norms. Accounting for the
variation in degree of intellectual disability both within
and between disorder groups will ensure that sleep dis-
turbance specificity is accounted for beyond associations
with severity of intellectual disability. Therefore, the
present study has the following aims:
1. To describe the profile of sleep disturbance in children
with SMS, AS, TSC and ASD compared to typically
developing children and to compare sleep disturbance
profiles between different neurodevelopmental disorder
groups
2. To evaluate the nature of the relationship between age
and sleep disturbance for each neurodevelopmental
disorder group
3. To describe associations between verbal ability,
behavioural (overactivity and impulsivity), health
(presence of seizures, severity of health problems,
presence of symptoms of gastro-oesophageal reflux)
and sleep disturbance variables for each
neurodevelopmental disorder group
4. To explore the association between sleep-disordered
breathing and obesity for each neurodevelopmental
disorder group
5. To examine the relationship between daytime
sleepiness and sleep-disordered breathing
Methods
Participants
Participants with AS, SMS, ASD and TSC were recruited
via the Angelman syndrome UK family support group
(ASSERT), the Foundation for Angelman Syndrome
Therapeutics in the USA, the Smith-Magenis Syndrome
Foundation UK, Autism West Midlands, Cerebra, the
Tuberous Sclerosis Association and existing databases
held by the Cerebra Centre for Neurodevelopmental
Disorders at the University of Birmingham. A commu-
nity sample of typically developing children was re-
cruited via friends and family of researchers at the
Cerebra Centre for Neurodevelopmental Disorders. Typ-
ically developing children were excluded if they held a
statement of education need that indicated an additional
need that may influence sleep, for example, ADHD and
hemiplegia. Demographic characteristics for the groups
are presented in Table 1.
The data in Table 1 demonstrate that significantly
fewer children with AS had 30 or more words or signs
in their vocabulary compared to children with ASD,
SMS or TSC. Significantly more children with AS and
TSC experienced seizures in the last month compared
with children with ASD and SMS. A significantly greater
proportion of children with AS were unable to walk un-
aided or lacked verbal language compared with all other
groups. Seventy one percent of children with AS used
sleep medication, compared with only 40% of children
with ASD and 30% of children with TSC. No other
significant differences were found between groups.
Procedure
Questionnaires were hosted via limeSurvey, and the in-
formation sheet, consent form and questionnaires were
accessed via a password-protected URL link. Paper cop-
ies of questionnaires were also made available. Families
were sent a link via email or by letter or accessed the
link via a syndrome support group Facebook page, the
Cerebra Centre for Neurodevelopmental Disorders Face-
book page or website.
Materials
The following questionnaires were administered. A
demographic questionnaire was included to obtain data
pertaining to the child’s age and diagnosis and verbal
ability (does your child have more than 30 words or
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signs in their vocabulary?) and whether their child is
able to walk unaided.
The Health Questionnaire [50] was administered to as-
sess the severity of any current (i.e. experienced within
the last month) medical condition. Severity was mea-
sured using a 4-point Likert scale (never, mild, moderate
or severe). The authors report good inter-rater reliability
for this questionnaire, with a mean Kappa value of .65
for the overall health problem score. Additional ques-
tions to assess medication usage were included.
The Activity Questionnaire (TAQ) [51] was adminis-
tered to assess the six aspects of hyperactivity and three
aspects of impulsivity described in the DSM IV. The
overactivity and impulsivity subscale scores were calcu-
lated according to the authors’ guidelines [52], and in
line with the recommendations, the impulsivity subscale
was pro-rated for immobile participants [52]. A 5-point
Likert scale measures the frequency of overactive and
impulsive behaviours over the last month, ranging from
‘never/almost never’ to ‘always/almost all of the time’.
Inter-rater reliability is good for both the impulsivity and
overactivity subscales (.74 and .70 respectively). Test-
retest reliability is also good for the impulsivity and
overactivity subscales (.88 and .87 respectively) [52].
The modified version of Simonds and Parraga’s sleep
questionnaire (MSPSQ) [12, 53] was administered to as-
sess sleep disturbance in the groups. The MSPSQ has
been validated for use with individuals aged 2 to 16 with
an autism spectrum disorder to include children with an
intellectual disability [53]. Questions address bedtime
routine and any severe settling, early morning waking or
night waking problems (that occur at least three times a
Table 1 Demographics of each group
AS
(n = 70)
SMS
(n = 26)
TSC
(n = 20)
ASD
(n = 30)
TD
(n = 47)
χ2 df p value Post hoc analysis (p < .01)
Mean age
(SD)
8.64
(3.77)
8.54
(3.08)
7.20
(4.11)
9.45
(3.47)
8.00
(3.24)
5.66 4 .226 –
Males (%) 45.7 61.5 55.0 70.0 66.0 7.50 4 .112 –
Genetic mechanism
(%)
Deletion 70.0 92.3 – –
Mutation 7.1 0 – –
TSC1 – – 15.0 –
TSC2 – – 60.0 –
UPD 11.4 0 – –
Imprinting 7.1 0 – –
Other 1.4 0 5.0 –
Translocation 1.4 3.8 – –
Clinical diagnosis 1.4 0 5.0 100.0
Unknown 0 3.8 0 0
Awaiting genetic
results
0 0 5.0 –
Missing data 10.0
BMI categorya Overweight (%) 28.9 25.0 26.3 13.0 – 1.76 4 .779 –
Speech Verbal (%) 8.6 84.6 80.0 76.7 100 120.88 4 < .001 TD, ASD, TSC; SMS > AS
Mobility Walk unaided (%) 72.9 100 100 96.7 100 41.31 4 < .001 TD, ASD, SMS; TSC > AS
Currently/occasionally using melatonin or other
sleep medication (%)
71.4 46.2 30.0 40.0 2.1 53.52 4 < .001 AS > ASD; TSC, ASD, SMS > TD
Symptoms indicative of reflux (%) 67.1b 64.0c 35.0 43.3 – 9.68 3 .021 AS > ASD, TSC
Seizures last month (%) 62.9 11.5 80.0 3.3 – 30.21 3 < .001 TSC > ASD, SMS; AS > ASD, SMS
Taking anti-epilepsy medication (%) 70.0 3.8 75.0 0 – 65.79 3 < .001 TSC > ASD, SMS; AS > SMS,
ASD
TAQ impulsivity mean
(SD)
15.25b
(5.19)
17.92
(2.65)
13.30
(7.17)
15.47
(4.92)
– 7.28 3 .064 –
TAQ overactivity mean
(SD)
17.40b
(9.16)
21.0c
(7.25)
16.0
(10.99)
21.57
(15.92)
– 5.01 3 .171 –
aData related to 64 children with AS, 15 children with SMS, 19 children with ASD and 18 children with TSC
bData only related to 30 children with AS
cData only related to 25 children with SMS
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week, taking over an hour to fall asleep, waking before 5
am or wakings that last over a few minutes) [54] as well
as any treatment that parents may have tried for their
child’s sleep and whether or not they considered the
treatment to be effective. The questionnaire assesses the
time of sleep onset and timings of nocturnal and day-
time sleep and sleep latency over the last month. A con-
firmatory factor analysis revealed five domains to the
MSPSQ: snoring, daytime sleepiness, complaints related
to sleep, sleep apnoea and anxiety related to sleep [55].
The questionnaire has adequate internal consistency (α
= .67) with total sleep quality scores correlating strongly
with the total scores on the widely used Child Sleep
Habits Questionnaire [53]. Questions about children’s
height and weight for BMI analysis were also obtained
from the MSPSQ. BMI scores were calculated by con-
verting all measurements to metric and using the equa-
tion weight (kg)/height2 (m). BMI percentiles were
derived using the Childhood and Puberty Close Moni-
toring chart developed by the Royal College of Paediat-
rics and Child Health for use with children with possible
growth or nutritional problems and recommended for
use in special schools [56]. Children with a BMI percent-
ile of 91 or above were classified as overweight as per
the chart’s guidelines. For the purpose of the analysis,
children classed as overweight were compared to chil-
dren with a healthy weight (children classed as under-
weight were excluded).
The Gastro-oesophageal Distress Questionnaire (GDQ)
[57] was administered to assess behaviours indicative of
gastro-oesophageal reflux. The GDQ measures the fre-
quency of a range of possible reflux symptoms on a 5-
point Likert scale ranging from ‘does not occur’ to ‘more
than once an hour’. The 17 items were assessed over the
last 2 weeks. Scores indicating the presence of five daily
occurring symptoms of possible gastro-oesophageal re-
flux were considered to be clinically significant. Ques-
tion 14 pertaining to night waking was removed to
ensure the independence of variables when comparisons
were made with sleep parameters.
Analysis
Data were tested for normality, and several variables
were found to be non-normally distributed; therefore,
non-parametric statistical tests were used. Differences
between groups for demographic variables were assessed
using chi-squared analyses. The MSPSQ subscale scores
and the portion of children who experience severe sleep
disturbances derived from the MSPSQ (nocturnal waking,
early morning waking, difficulty settling/initiating sleep)
were compared between groups using chi-squared or
Kruskal-Wallis tests. Post hoc Mann-Whitney U tests
were used to identify the significant between group
differences for continuous variables.
Effect sizes were evaluated using Cohen’s r (z/square root
of N) which is equivalent to Cohen’s d for non-parametric
tests. In light of the lack of literature using effect sizes to
evaluate sleep disturbance in children with neurodevelop-
mental disorders, guidelines to interpret Cohen’s r using
values outlined by Cohen [58] were used (.2 = small effect,
.5 =medium effect, .8 = large effect [59]).
Odds ratios were used for nominal data and arbitrary
cut-offs for illustration in Table 6. To reduce type I
error, an alpha level of p < .01 was applied.
Spearman correlations were used to explore the rela-
tionships between age, health, overactivity, impulsivity
and MSPSQ scores. Spearman correlations were also
used to explore the relationships between overactivity/
impulsivity and daytime drowsiness/sleep-disordered
breathing. Due to the lack of independence between the
overactivity subscale and the daytime sleepiness sub-
scale, which contained an item about whether children
were more active during the day than other children,
only the drowsiness item “seems drowsy but can stop
themselves falling asleep” was included in this analysis.
Cronbach’s alphas were calculated for the daytime
sleepiness subscale for each neurodevelopmental dis-
order group. Cronbach’s alpha scores for each group
averaged .20 (range − .09 to .38). The published psycho-
metrics for the MSPSQ also reveal poor internal
consistency for the daytime sleepiness subscale. Despite
the poor internal consistency, the use of one item, drow-
siness, was chosen to represent daytime sleepiness as the
lack of independence of the more active item would have
undermined the validity of the analysis.
Mann-Whitney U tests were used to examine the pu-
tative association between verbal ability, presence of sei-
zures (AS and TSC groups only due to small subsamples
of children with SMS and ASD experiencing seizures;
see Table 1) and meeting cut-off score for symptoms in-
dicative of gastro-oesophageal reflux and differences in
sleep questionnaire subscale scores. A Kruskal-Wallis
test was conducted to compare MSPSQ subscales be-
tween the genotypes of AS.
Results
Relationship between sleep medication, epilepsy
medication use and sleep disturbance for each
neurodevelopmental disorder group
The demographic information in Table 1 reveals that
significantly more children in the AS group took medi-
cation to improve their sleep quality than children with
ASD and TSC. Children with ASD who took medication
to improve sleep quality had significantly higher scores
on the night waking subscale (U = 31.5, p = .001) than
children who did not take sleep medication. No other
significant differences in any of the other groups were
found between children who did and did not take sleep
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or epilepsy medication. Therefore, all further analyses
were conducted combining those who did and did not
take medication to improve their sleep.
Comparing sleep between children with
neurodevelopmental disorders and typically developing
children (aim 1)
The first aim of the study was to compare sleep disturb-
ance in children with each neurodevelopmental disorder
to that of typically developing children and to contrast
sleep between neurodevelopmental groups. The results
of the comparisons between each neurodevelopmental
group and the TD contrast group are presented in
Tables 2 and 3.
The data in Table 2 demonstrate that all neurodeve-
lopmental disorder groups had significantly higher
scores on the night waking, daytime sleepiness and the
parasomnia subscales in comparison with the TD con-
trast group. Medium-sized effects were evident for para-
somnia scores in the SMS group and for daytime
sleepiness scores for both the SMS and AS groups.
Children with AS and SMS obtained significantly
higher night waking scores compared to the TD contrast
group, with medium effect sizes. Children with SMS, AS
and ASD (trend only) had significantly higher scores on
the sleep-disordered breathing subscale compared with
the TD contrast group (small effect sizes for AS and
ASD groups, medium effect size for the SMS group). A
significantly higher score on the sleep onset latency sub-
scale was found for children with ASD compared with
the TD contrast group (medium effect size), whilst
higher scores on the sleep onset latency subscale for the
TSC versus the TD group represented a small non-
significant effect size. The data in Table 4 show the pro-
files of sleep disturbance across children with ASD, TSC,
SMS and AS.
Children with TSC co-slept with another person at
sleep onset or during the night significantly more
frequently than TD children, and a trend towards
significance was found for children with AS relative to
TD children (p = .011; see Additional file 1: Table S1). A
significantly greater proportion of children with SMS
had severe early morning waking problems compared to
all other groups and severe night waking problems
compared children in the ASD, AS and TD groups.
Children with SMS had significantly higher sleep-
disordered breathing scores than children in all other
groups (p < .01) and significantly higher daytime
sleepiness scores compared to children with TSC and
ASD (p < .01, see Additional file 1: Table S1).
Significantly more children with ASD had severe
settling problems than children with AS (p < .001), and
children with ASD also had significantly higher bedtime
resistance scores than children with AS (p = .002).
Children with ASD had significantly higher sleep onset
latency scores than all other groups (p < .01, see
Additional file 1: Table S1).
Relationships between sleep disturbance and age (aim 2)
There was a significant negative correlation between age
and night waking scores for children with AS; hence,
night waking appears to decrease with age (rs = −.32 p
= .008). There were no other significant relationships be-
tween age and sleep quality for children with AS, SMS,
TSC, ASD or the TD contrast group.
Relationships between children’s sleep disturbance, verbal
ability, health conditions, epilepsy and behaviour (aim 3)
Relationships between sleep disturbance and verbal ability
Children with ASD classed as ‘non-verbal’ (having less
than 30 words or signs in their vocabulary) were more
likely to experience severe early waking problems
(57.1%) compared with children classed as verbal (13.0%,
trend towards significance χ2 = 5.83, p = .016). There
were no significant differences in the proportion of ver-
bal and non-verbal children who experienced severe
sleep problems for any of the neurodevelopmental
disorder groups.
Relationships between sleep disturbance and the severity of
health conditions
Higher sleep-disordered breathing (rs = .60, p < .001) and
parasomnias scores (rs = .36, p = .05, trend only) were
related to the severity and number of heath conditions
experienced by children with AS. Higher night waking
Table 2 Effect sizes for MSPSQ comparisons for each
neurodevelopmental disorder group compared to the TD group
AS–TD SMS–TD TSC–TD ASD–TD
Sleep anxietya – − .09 − .01 − .18
Bedtime resistanceb − .07 − .19 − .12 − .27†
Sleep onset latency − .11 − .11 − .22† − .59**
Night wakingb − .60** − .76** − .35* − .49*
Sleep-disordered breathingb − .47* − .68** − .17 − .30†
Parasomniab − .45* − .64** − .38* − .46*
Daytime sleepiness − .60** − .73** − .40* − .44*
Drowsy during the day − .49* − .83** − .36* − .38*
Co-sleepingc − .29† − .22† − .35* − .20†
aDue to the majority of items on the sleep anxiety subscale requiring verbal
ability, this subscale score was not calculated for children with AS
bMissing data. Children with ASD: sleep anxiety, bedtime resistance, sleep-
disordered breathing and parasomnias (n = 29). Children with SMS: bedtime re-
sistance (n = 25), sleep-disordered breathing and parasomnias (n = 24). TD
children: night waking (n = 43), sleep-disordered breathing (n = 44), sleep onset
latency (n = 45), parasomnias (n = 46)
cCo-sleeping item was not administered to 40 children with AS, n = 30 for
this item
*r ≥ .2—small effect, **r ≥ .5—medium effect (Cohen, [58]), †non-significant
effect size, p > .01
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(rs = .54, p = .013, trend only), sleep-disordered breathing
(rs = .62, p = .004) and parasomnias (rs = .63, p = .003)
were all positively related to the severity and frequency
of health conditions in children with TSC. There were
no other associations between sleep subscales and sever-
ity of health conditions for any other groups.
Relationships between sleep disturbance and severity of
epilepsy
Due to the very small numbers of children who had ex-
perienced seizures or neurological referrals in the last
month in the SMS and ASD groups, these groups were
not included in this analysis. There were no significant
differences in any of the sleep subscale scores between
children who had or had not experienced seizures/
neurological referrals in the last month for children in
the AS and TSC groups.
Relationships between sleep disturbance and severity of
symptoms indicative of gastro-oesophageal reflux
The 67% of children with AS who scored above the
clinical cut-off for behavioural symptoms indicative of
gastro-oesophageal reflux (hereafter referred to as
GORD symptoms) had significantly higher scores on the
sleep-disordered breathing (U = 319.0, p = .005) and
parasomnia subscales (U = 300.0, p = .003). There was a
trend towards significance for higher daytime sleepiness
scores for children who scored above the clinical cut-off
Table 3 Odds ratios for MSPSQ comparisons for each neurodevelopmental disorder group compared to the TD group
AS–TD SMS–TD TSC–TD ASD–TD
Severe night waking problems 18.95
(4.26–84.27)
94.50
(16.92–527.57)
18.41
(3.47–97.60)
17.21
(3.51–84.36)
Severe early morning waking problems 10.49
(1.32–83.20)
124.86
(14.37–1085.24)
8.12
(.79–83.48)
14.0
(1.62–120.70)
Severe settling problems 1.01
(.16–6.27)
1.88
(.25–14.16)
3.97
(.61–25.87)
9.64
(1.91–48.60)
Table 4 Median (interquartile range) sleep subscale scores, proportions of children with severe sleep problems and statistical
comparisons
ASa SMS TSC ASD TD Kruskal-Wallis
comparison
Between group
comparison corrected
to p < .01df χ2 P
Sleep anxiety – 11.50
(8.75–13.00)
9.00
(7.25–13.00)
13.00
(9.00–14.50)
10.00
(8.00–13.00)
3 2.90 .408 –
Bedtime resistance 10.00
(7.00–13.00)
14.00
(9.00–16.00)
11.00
(10.0–16.75)
15.00
(9.00–18.00)
11.00
(8.00–14.00)
4 12.85 .012 ASD > AS
Sleep onset latency 2.00
(2.00–3.00)
2.00
(1.00–2.00)
2.50
(2.00–3.00)
3.00
(3.00–5.00)
2.00
(1.00–3.00)
4 36.16 < .001 ASD > SMS, AS, TSC, TD
Night waking 7.00
(5.00–8.00)
7.00
(7.00–8.00)
6.00
(3.25–8.00)
7.00
(4.00–9.00)
3.00
(2.00–5.00)
4 51.72 < .001 ASD, SMS, AS, TSC > TD
Sleep-disordered
breathing
9.00
(6.00–11.00)
11.50
(9.00–16.00)
5.00
(5.00–10.75)
7.00
(5.00–11.00)
5.00
(5.00–8.00)
4 40.32 < .001 SMS > ASD, AS, TSC, TD
AS > TD
Parasomnia 19.00
(15.00–23.00)
21.50
(18.50–26.75)
19.50
(15.00–23.25)
22.00
(16.00–27.50)
14.50
(11.75–18.00)
4 40.23 < .001 SMS, AS, ASD, TSC > TD
Daytime sleepiness 6.00
(4.00–7.00)
6.00
(6.00–9.00)
6.00
(2.00–6.00)
6.00
(2.00–6.25)
2.00
(2.00–3.00)
4 54.89 < .001 SMS > ASD, TSC, TD
AS, ASD, TSC > TD
Drowsy during the
day
2.00
(1.00–3.00)b
4.50
(3.00–5.00)
1.00
(1.00–2.75)
1.00
(1.00–3.00)
1.00
(1.00–1.00)
4 62.80 < .001 SMS > AS, ASD, TSC, TD
AS, ASD, TSC > TD
Co-sleeping 1.5 (1.00–5.00) 1.00
(1.00–4.50)
2.5
(1.00–5.00)
1.00
(1.00–5.00)
1.00
(1.00–2.00)
4 10.58 .032 TSC > TD
Severe night waking (%) 45.70 80.80 45.0 43.30 4.30 4 44.37 < .001 SMS > AS, ASD, TD
TSC, AS, ASD > TD
Severe early morning
waking (%)
18.60 73.10 15.0 23.30 2.10 4 50.95 < .001 SMS > TSC, AS, ASD, TD
AS, ASD > TD
Severe settling (%) 4.30 7.70 15.0 30.0 4.30 4 18.56 .001 ASD > AS, TD
aThere were no significant differences on any of the MSPSQ subscales between the AS genetic subtypes
bCo-sleeping item was not administered to 40 children with AS, n = 30 for this item
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for indicative GORD symptoms compared to children
without clinical symptoms (366.0, p = .025).
Children with ASD who scored above the clinical cut-off
for behavioural symptoms indicative of gastro-oesophageal
reflux (hereafter referred to as GORD symptoms) had sig-
nificantly higher scores on the night waking (U = 49.0, p
= .009), parasomnia (U = 31.0, p = .001) and the sleep-
disordered breathing subscales (U = 45.0, p = .009) than
children with ASD who did not score above the cut-off. A
trend towards significance was also found for children with
ASD with GORD symptoms for increased daytime sleepi-
ness (U = 53.0, p = .015).
Children with SMS with GORD symptoms had signifi-
cantly higher sleep-disordered breathing scores (U = 8.5,
p = .001). Children with TSC experiencing GORD symp-
toms had significantly higher scores on the sleep onset
latency (U = 11.0, p = .005) and night waking scores (U =
11.0, p = .005) than children not meeting the cut-off for
clinical GORD symptoms. A trend towards significance
was also found for children with TSC with GORD symp-
toms for higher scores on the bedtime resistance (U = 16.5,
p = .019) and parasomnia (U = 19.5, p = .037) subscales
compared to children without GORD symptoms.
Relationships between overactivity and impulsivity and
sleep disturbance
The associations between sleep parameters and over-
activity/impulsivity are presented in Table 5.
The data in Table 5 reveal that higher impulsivity sub-
scale scores were moderately positively correlated with
increased sleep onset latency and daytime drowsiness in
children with SMS (both trend only, p < .05). Overactiv-
ity scores were associated with higher sleep onset latency
and parasomnias scores in the SMS group (moderate as-
sociations, both trend only). Children with ASD’s sleep
onset latency (trend only) and parasomnias scores were
moderately correlated with the overactivity subscale
score in a positive direction. Night waking and parasom-
nias scores were strongly positively correlated with the
overactivity score in children with TSC.
Severity of sleep-disordered breathing and daytime
drowsiness (trend only) were moderately correlated with
overactivity scores in the TSC group. The impulsivity sub-
scale score was significantly strongly positively correlated
with increased night waking and was significantly posi-
tively correlated with the bedtime resistance score
reflecting a moderate effect size in the TSC group
(trend only).
Relationship between sleep-disordered breathing and
obesity (aim 4)
Sleep-disordered breathing scores for children classed as
overweight, very overweight or severely obese were com-
pared to those of children with a healthy weight. No
significant differences in sleep-disordered breathing
scores were found between healthy and overweight
children with TSC, AS, SMS or ASD.
Relationships between daytime drowsiness and
sleep-disordered breathing (aim 5)
No significant relationships were found between daytime
drowsiness and sleep-disordered breathing.
Discussion
This study compared the profile of sleep disturbance
across children with AS, SMS, TSC and ASD and com-
pared the syndrome profiles to a chronologically age-
matched TD contrast group. Children with AS, SMS, TSC
and ASD had significantly higher night waking, parasom-
nia and daytime sleepiness scores compared to typically
developing children; hence, there is evidence of broad
vulnerability to sleep disturbance for children with
neurodevelopmental disorders. Different profiles of sleep
disturbance emerged when comparing different neurode-
velopmental disorder groups, evidencing specificity of cer-
tain sleep disturbances in specific neurodevelopmental
disorder groups; for example, sleep-disordered breathing
and early morning waking were the most severe for
children with SMS compared to other disorder groups.
Children with ASD had a profile of sleep disturbance
reflecting difficulties with sleep onset which was more se-
vere than children with SMS, AS and TSC and typically
developing children. The data in Table 6 highlight the pro-
file of sleep-related disturbances compared to the TD
group. The use of effect sizes enables the standardisation
of results for each group compared to the TD group, to
compare the relative severity of sleep disturbance for each
group, despite the different sample sizes.
The evidence of daytime sleepiness or drowsiness,
night time waking and parasomnias across the disorder
groups as shown in Table 6 indicates that these sleep-
related disturbances should be routinely assessed. The
results of this study demonstrate that sleep disturbances
are problematic in children with TSC, relative to typic-
ally developing children, even if no specific profile of
sleep disturbance emerged compared to other disorder
groups. These findings contrast with those of Hunt and
Stores [5], who found children with TSC to experience
settling in addition to night waking disturbance com-
pared to a group of children with an intellectual disabil-
ity of heterogeneous origin and typically developing
children. Differences between the findings in the present
study and the study by Hunt and Stores (1994) may be
explained by differences in sample size; 20 parents of
children with TSC completed the current study versus
40 parents in Hunt and Stores’ study. It is also possible
that given the significant heterogeneity in TSC, children
in the two studies may have differed in their degree of
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intellectual disability, as children with a moderate to se-
vere level of intellectual disability in Hunt and Stores’
study had poorer overall sleep quality as measure by a
sleep index score.
The profiles of sleep disturbance for children with
ASD, SMS and AS delineated in the present study sup-
port and extend the current literature on sleep in these
disorders. These data demonstrate that children with
ASD predominantly experience difficulties with night
waking and settling, children with SMS primarily experi-
ence night waking and early morning waking problems
and children with AS primarily experience night waking
difficulties, followed by early waking problems. The
comparison of profiles of sleep disturbance across neu-
rodevelopmental groups reveals that in some groups,
sleep disturbance profiles affect the group homoge-
nously, whilst in other groups, sleep disturbance severity
and profile differs to a greater extent between children.
This is apparent when comparing the frequency of se-
vere sleep problems in children with SMS and AS. Half
of the sample with AS did not experience any severe
sleep problems, compared with only 8% of children with
SMS. This is important when considering the specificity
of sleep disturbance for each disorder group. It could be
argued that early morning waking reflects partial
specificity for SMS, as whilst 23% of children with ASD
also experienced this problem, the majority (73%) of
children with SMS experienced early morning waking.
In contrast, severe night waking is less easily justified as
reflecting partial specificity for children with AS, ASD
and TSC as less than half of the children in each group
experienced this disturbance. It could therefore be ar-
gued that children with AS, ASD and TSC are at higher
risk of experiencing night waking, but it should not be
considered a consistent feature of the phenotype of each
disorder. Whereas 92% of children with SMS experi-
enced some form of severe sleep disturbance, therefore,
sleep disturbance could be argued to form part of the
phenotype of SMS. Nonetheless, the presence of severe
sleep disturbance for some children with AS, TSC and
ASD means that clinicians must ensure that families are
supported with appropriate assessment of and treatment
for sleep disturbance where necessary.
No relationships between age and sleep disturbance
were found for children with ASD, TSC and SMS. How-
ever, a negative relationship with age and night waking
scores was found for the AS group. As the neurodeve-
lopmental groups were well matched for chronological
age, this suggests that the finding that night waking de-
creases with age in AS is a syndrome-specific character-
istic, supporting previous research [11, 21]. It is also of
clinical importance for families and professionals as this
finding suggests that sleep disturbance may improve as
children enter their teenage years. However, due to the
cross-sectional nature of this study, this finding needs to
be interpreted with caution and substantiated with a
large-scale longitudinal study of sleep quality in children
with AS.
The data from this study revealed that variation in
sleep disturbance prevalence within the AS group could
not be explained by differences between different geno-
types of AS, although only small numbers of children
without the UBE3A deletion genotype were included in
the study. These findings reflect those of two out of
three previous studies [11, 60, 61].
Table 5 Spearman’s correlations between overactivity and impulsivity and sleep quality
Anxiety Bedtime resistance Sleep onset latency Night waking Sleep-disordered breathing Parasomnias Drowsiness
ASa Overactivity rs – .055 .179 .232 .308 .232 .332
Impulsivity rs – .323 − .077 .150 − .031 .181 − .145
SMS Overactivity rs − .182 − .004 .433* .034 .199 .443* − .043
Impulsivity rs .032 .059 .396* .109 .350 .273 .478*
TSC Overactivity rs .057 .329 .247 .725** .576** .628** .477*
Impulsivity rs .162 .480* .262 .785** .271 .362 .244
ASD Overactivity rs − .060 .202 .435* .249 − .089 .497** .045
Impulsivity rs .171 .318 .245 .266 − .009 .199 − .006
*p < .05, **p < .01
aDue to the majority of verbal items on the sleep anxiety subscale, children with AS were not included in this analysis
Table 6 Profiles of sleep disturbance in children with ASD, SMS,
AS and TSC compared to TD children
AS SMS TSC ASD
Sleep anxiety – O O O
Bedtime resistance O O O +
Sleep onset latency O O + ++
Night waking ++ ++ + +
Sleep-disordered breathing + ++ O +
Parasomnias + ++ + +
Daytime sleepiness ++ ++ + +
Severe early morning waking problems ++ +++ + ++
O effect size r < 0.2, + small effect size r 0.20–0.49 or odds ratio 0.2–9.0, ++
medium effect size r 0.5–0.8 or odds ratio 10.0–49.0, +++ odds ratio > 50
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Children with ASD who were classed as non-verbal
were more likely to experience early morning waking
problems than children who were verbal (trend only).
This could be attributed to children’s poorer ability to
self-soothe, although lack of verbal ability cannot be
substituted for poorer adaptive ability skills. This sup-
ports previous research [62]. No other associations be-
tween verbal ability or adaptive functioning and sleep
parameters were identified for any group.
Mixed relationships were identified between sleep dis-
turbances and neurological and health problems (see
Table 7 for a summary of significant associations). No
relationship between the experience of seizures in the
last month and severity of sleep disturbance was found
for either children with AS or children with TSC. This
finding for children with AS was consistent with the
existing mixed literature. However, it does not support a
previous study in children with TSC [5]. Future research
should use a validated questionnaire measure to assess
seizure severity and correlate this with sleep disturbance,
and should evaluate the relationship between nocturnal
seizures and sleep disturbance on a night by night basis.
For children with more health problems, in this study
children with AS and TSC, a greater severity and num-
ber of health problems were associated with higher
sleep-disordered breathing and parasomnias (TSC only).
Symptoms indicative of GORD were associated with
sleep-disordered breathing (AS, SMS and ASD groups)
and parasomnias (AS and ASD groups). Children with
symptoms indicative of GORD had significant higher
night waking and sleep onset latency scores in the TSC
group and higher night waking scores in the ASD group.
However, as the questionnaire to assess GORD symp-
toms has not yet been validated, these findings should
be interpreted with caution. These findings are sup-
ported by a recent study that demonstrated that children
with ASD with gastrointestinal symptoms were signifi-
cantly more likely to have interrupted sleep than chil-
dren without gastrointestinal symptoms [63]. These
findings demonstrate the importance of considering
children’s broader health in relation to sleep quality, in
particular with regard to mechanism between sleep-
disordered breathing and GORD symptoms, as noctur-
nal arousals associated with gastro-oesophageal reflux
have been detailed in previous research [64]. Greater
sleep disturbance for children with AS or TSC with
painful health conditions presents a clear first-line inter-
vention for sleep disorders in children with neurodeve-
lopmental disorders at risk of pain. These findings build
upon the evidence of the importance of assessing and
treating pain in children with neurodevelopmental disor-
ders as a priority [65].
This is the first study, to the authors’ knowledge, to
identify sleep-disordered breathing as a specific problem
in children with SMS. The mechanisms underlying
sleep-disordered breathing in this group remain unclear,
as despite over a quarter of the sample of children with
SMS having a BMI classified as overweight or obese, no
significant difference in sleep-disordered breathing
scores was found between these children and those who
had a healthy weight or who were underweight. How-
ever, with missing data for BMI for 38% of the SMS
sample, these data do need to be interpreted with cau-
tion. An alternative hypothesis is that the midface hypo-
plasia associated with SMS is associated with sleep-
disordered breathing in this group. Midface hypoplasia,
in which the mandibular (lower jaw) protrudes relative
to the maxilla, affects over 90% of individuals with SMS
and has been associated with obstructive sleep apnoea
[66–68]. Similarly, for children with AS, despite obtain-
ing higher sleep-disordered breathing scores than the
TD contrast group, no relationship was found between
BMI status and sleep-disordered breathing scores. Im-
portantly, the AS group had complete BMI data for 94%
of the sample. These data support findings from a previ-
ous questionnaire study that identified higher sleep-
disordered breathing and snoring scores in children with
AS compared to typically developing children [11]. How-
ever, it is important to note that the modified Simonds
and Parraga sleep questionnaire used in the present
Table 7 Summary of significant (p < .01) associations between sleep disturbance, health conditions and behaviour for each group
AS SMS TSC ASD
Age + age/night waking N/A N/A N/A
Health + number and severity of
health conditions/sleep
disordered breathing
+ symptoms indicative of
GORD/sleep-disordered
breathing/parasomnias
+ symptoms indicative of
GORD/sleep-disordered
breathing
+ number and severity of
health conditions/sleep-
disordered breathing/
parasomnias
+ symptoms indicative of
GORD/sleep onset latency/
night waking
+ symptoms indicative
of GORD/night waking/
parasomnias/sleep-
disordered breathing
Overactivity and impulsivity N/A N/A + overactivity and impulsivity/
night waking
+ overactivity/parasomnias/
sleep-disordered breathing
+ overactivity/parasomnias
N/A no significant correlation, p > .01; + significant positive correlation
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study assessed sleep-disordered breathing based upon
parental report. These scores are not interchangeable
with a diagnosis of obstructive sleep apnoea which can
only be assessed using polysomnography. Thus, further
research is needed to assess the prevalence of obstruct-
ive sleep apnoea in children with SMS and AS using
polysomnography.
No relationship was found between sleep-disordered
breathing and daytime drowsiness, in contrast to litera-
ture cited in a recent systematic review [34]. However,
the review only referred to two studies that had evalu-
ated daytime sleepiness in the typically developing popu-
lation objectively using the multiple sleep onset latency
test. Therefore, further research should be conducted
using a validated measure of daytime sleepiness in
groups of children with neurodevelopmental disorders.
This was the first study to investigate the putative as-
sociation between daytime sleepiness and overactivity
and impulsivity in children with specific neurodevelop-
mental disorders. The emerging pattern of trend towards
significant moderate correlations for two out of the four
groups for overactivity or impulsivity and daytime drow-
siness was an important finding. The results identified a
positive correlation between overactivity and daytime
drowsiness (trend only) and night waking for children
with TSC. However, no relationships between sleep-
disordered breathing and overactivity or impulsivity were
found for children with SMS or AS, for whom the high-
est sleep-disordered breathing scores was identified. In
addition, when the relationship between daytime drowsi-
ness and sleep-disordered breathing was examined, no
relationship for any of the neurodevelopmental disorder
groups was found. Moreover, the sensitivity of both the
drowsiness item and the sleep-disordered breathing sub-
scale when investigating this relationship has not been
established. Further research is needed to investigate the
nature of the relationship between sleep-disordered
breathing, overactivity and impulsivity and daytime
sleepiness. This is particularly important to establish
whether sleep-disordered breathing, which can be
treated, impacts adversely children’s behaviour and day-
time functioning.
Limitations
This study provides the first broad overview of sleep dis-
turbance in a cross-comparison study of four neurodeve-
lopmental disorders compared to a typically developing
sample. It is important to note that the neurodevelop-
mental groups comprise relatively small samples with
wide age ranges from 2 to 15 years. Future studies
should seek to evaluate whether the results reported
here are replicable in larger samples and whether they
are representative for children of differing ages. A broad
categorisation of verbal ability, 30 words or signs were
used to identify children as verbal or non-verbal in this
study, which may have underestimated children’s ability
to use non-verbal communication with caregivers.
Future research should include a comprehensive measure
to assess verbal and non-verbal communication and the
relationship with sleep disturbance and include the
assessment of IQ and adaptive functioning as reliable
measures of ability.
Conclusions
This study was the largest to date incorporating sleep
disturbance questionnaire data from children with four
distinct neurodevelopmental disorders using a measure
designed for use with this population. This methodology
has revealed broad vulnerability to sleep problems across
neurodevelopmental disorders, such as night waking,
but also partial specificity of sleep problems pertaining
to early morning waking in SMS, and sleep-disordered
breathing in children with SMS and AS. Risk profiles for
sleep disturbances in each group were identified through
the use of a typically developing contrast group. Whilst
there were limitations to the evaluation of daytime
sleepiness in this study, there are implications for the
agenda for future research, particularly evaluating the re-
lationship between sleep-disordered breathing and day-
time sleepiness using polysomnography. These results
provide further evidence for the importance of consider-
ing health issues in relation to sleep disturbance, as
symptoms indicative of gastro-oesophageal reflux were
associated with sleep-disordered breathing for the AS,
SMS and ASD groups, whilst a greater number and sever-
ity of health conditions were associated with higher sleep-
disordered breathing scores for children with AS and
TSC. Taken together, these results enable delineation of
syndrome-specific profiles of sleep disturbance in children
with AS, SMS, TSC and ASD and have compared their
severity to those experienced by TD children.
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